Prot # ISIS 396443-CS3B: Phase 3, Randomized, Double-blind, Sham-Procedure Controlled Study to Assess the Clinical Efficacy and Safety of ISIS 396443 Administered Intrathecally in Patients with Infantile-onset Spinal Muscular Atrophy

Project: Research project

Project Details

Effective start/end date12/2/1412/2/17


  • Ann & Robert H. Lurie Children’s Hospital of Chicago (ISIS 396443-CS3B // ISIS 396443-CS3B)
  • Isis Pharmaceuticals, Inc. (ISIS 396443-CS3B // ISIS 396443-CS3B)